Bhaven N. Sampat

Bhaven N. Sampat is an economist by training, a Professor at the Department of Health Policy and Management at Columbia University, and a Research Associate at the National Bureau of Economic Research (NBER).

Bhaven has written extensively on life science and pharmaceutical innovation policy, including work on U.S. pharmaceutical patenting, brand–generic competition, gene patents and follow–on innovation, the globalization of patent protection, academic entrepreneurship, the roles of public sector in pharmaceutical innovation, and the politics and economics of the NIH. He is a member of the Editorial Advisory Board at Milbank Quarterly, the Steering Committee of the NBER Innovation Information Initiative, and the Steering Committee of Columbia’s Precision Medicine and Society Initiative.

Read more at: https://www.nber.org/people/bhaven_sampat